Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆

Bibliographic Details
Main Authors: Tedesco, Ana Paula, Martins, Juliana Saccol, Nicolini-Panisson, Renata D’Agostini
Format: Online
Language:English
Published: Elsevier 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511629/
id pubmed-4511629
recordtype oai_dc
spelling pubmed-45116292015-07-30 Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆ Tedesco, Ana Paula Martins, Juliana Saccol Nicolini-Panisson, Renata D’Agostini Original Article Elsevier 2014-05-10 /pmc/articles/PMC4511629/ /pubmed/26229827 http://dx.doi.org/10.1016/j.rboe.2014.04.022 Text en © 2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Tedesco, Ana Paula
Martins, Juliana Saccol
Nicolini-Panisson, Renata D’Agostini
spellingShingle Tedesco, Ana Paula
Martins, Juliana Saccol
Nicolini-Panisson, Renata D’Agostini
Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆
author_facet Tedesco, Ana Paula
Martins, Juliana Saccol
Nicolini-Panisson, Renata D’Agostini
author_sort Tedesco, Ana Paula
title Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆
title_short Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆
title_full Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆
title_fullStr Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆
title_full_unstemmed Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects☆☆☆
title_sort focal treatment of spasticity using botulinum toxin a in cerebral palsy cases of gmfcs level v: evaluation of adverse effects☆☆☆
description
publisher Elsevier
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511629/
_version_ 1613250916508499968